475 related articles for article (PubMed ID: 27839893)
1. Auranofin inactivates Trichomonas vaginalis thioredoxin reductase and is effective against trichomonads in vitro and in vivo.
Hopper M; Yun JF; Zhou B; Le C; Kehoe K; Le R; Hill R; Jongeward G; Debnath A; Zhang L; Miyamoto Y; Eckmann L; Land KM; Wrischnik LA
Int J Antimicrob Agents; 2016 Dec; 48(6):690-694. PubMed ID: 27839893
[TBL] [Abstract][Full Text] [Related]
2. Gold(I) Phosphine Derivatives with Improved Selectivity as Topically Active Drug Leads to Overcome 5-Nitroheterocyclic Drug Resistance in
Miyamoto Y; Aggarwal S; Celaje JJA; Ihara S; Ang J; Eremin DB; Land KM; Wrischnik LA; Zhang L; Fokin VV; Eckmann L
J Med Chem; 2021 May; 64(10):6608-6620. PubMed ID: 33974434
[No Abstract] [Full Text] [Related]
3. Diamine derivative anti-Trichomonas vaginalis and anti-Tritrichomonas foetus activities by effect on polyamine metabolism.
Rigo GV; Trein MR; da Silva Trentin D; Macedo AJ; de Oliveira BA; de Almeida AM; Giordani RB; de Almeida MV; Tasca T
Biomed Pharmacother; 2017 Nov; 95():847-855. PubMed ID: 28903180
[TBL] [Abstract][Full Text] [Related]
4. Phytochemical-rich foods inhibit the growth of pathogenic trichomonads.
Noritake SM; Liu J; Kanetake S; Levin CE; Tam C; Cheng LW; Land KM; Friedman M
BMC Complement Altern Med; 2017 Sep; 17(1):461. PubMed ID: 28903731
[TBL] [Abstract][Full Text] [Related]
5. 20S Proteasome as a Drug Target in Trichomonas vaginalis.
O'Donoghue AJ; Bibo-Verdugo B; Miyamoto Y; Wang SC; Yang JZ; Zuill DE; Matsuka S; Jiang Z; Almaliti J; Caffrey CR; Gerwick WH; Eckmann L
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451503
[TBL] [Abstract][Full Text] [Related]
6. Anti-trichomonad activities of different compounds from foods, marine products, and medicinal plants: a review.
Friedman M; Tam CC; Cheng LW; Land KM
BMC Complement Med Ther; 2020 Sep; 20(1):271. PubMed ID: 32907567
[TBL] [Abstract][Full Text] [Related]
7. The flavin inhibitor diphenyleneiodonium renders Trichomonas vaginalis resistant to metronidazole, inhibits thioredoxin reductase and flavin reductase, and shuts off hydrogenosomal enzymatic pathways.
Leitsch D; Kolarich D; Duchêne M
Mol Biochem Parasitol; 2010 May; 171(1):17-24. PubMed ID: 20093143
[TBL] [Abstract][Full Text] [Related]
8. Genetic Indicators of Drug Resistance in the Highly Repetitive Genome of Trichomonas vaginalis.
Bradic M; Warring SD; Tooley GE; Scheid P; Secor WE; Land KM; Huang PJ; Chen TW; Lee CC; Tang P; Sullivan SA; Carlton JM
Genome Biol Evol; 2017 Jun; 9(6):1658-1672. PubMed ID: 28633446
[TBL] [Abstract][Full Text] [Related]
9. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.
Leitsch D
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):321-327. PubMed ID: 28910741
[TBL] [Abstract][Full Text] [Related]
10. Effect of the antimicrobial peptide, D-hecate, on trichomonads.
Mutwiri GK; Henk WG; Enright FM; Corbeil LB
J Parasitol; 2000 Dec; 86(6):1355-9. PubMed ID: 11191917
[TBL] [Abstract][Full Text] [Related]
11. Trichomonads, hydrogenosomes and drug resistance.
Kulda J
Int J Parasitol; 1999 Feb; 29(2):199-212. PubMed ID: 10221623
[TBL] [Abstract][Full Text] [Related]
12. Antiparasitic activity of furanyl N-acylhydrazone derivatives against Trichomonas vaginalis: in vitro and in silico analyses.
Alves MSD; das Neves RN; Sena-Lopes Â; Domingues M; Casaril AM; Segatto NV; Nogueira TCM; de Souza MVN; Savegnago L; Seixas FK; Collares T; Borsuk S
Parasit Vectors; 2020 Feb; 13(1):59. PubMed ID: 32046788
[TBL] [Abstract][Full Text] [Related]
13. Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus.
Bouma MJ; Snowdon D; Fairlamb AH; Ackers JP
J Antimicrob Chemother; 1998 Dec; 42(6):817-20. PubMed ID: 10052908
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
[TBL] [Abstract][Full Text] [Related]
15. The Caatinga endemic Manilkara rufula possesses remarkable activity against Trichomonas vaginalis and Tritrichomonas foetus.
de Brum Vieira P; Feijó Silva NL; Silva DB; Lopes NP; da Silva AG; da Silva MV; Bastida J; Macedo AJ; Tasca T
Exp Parasitol; 2017 Feb; 173():18-28. PubMed ID: 27956086
[TBL] [Abstract][Full Text] [Related]
16. Use of an animal model of trichomoniasis as a basis for understanding this disease in women.
Corbeil LB
Clin Infect Dis; 1995 Oct; 21 Suppl 2():S158-61. PubMed ID: 8845444
[TBL] [Abstract][Full Text] [Related]
17. Pentamycin shows high efficacy against Trichomonas vaginalis.
Kranzler M; Syrowatka M; Leitsch D; Winnips C; Walochnik J
Int J Antimicrob Agents; 2015 Apr; 45(4):434-7. PubMed ID: 25703311
[TBL] [Abstract][Full Text] [Related]
18. Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance.
Leitsch D; Kolarich D; Binder M; Stadlmann J; Altmann F; Duchêne M
Mol Microbiol; 2009 Apr; 72(2):518-36. PubMed ID: 19415801
[TBL] [Abstract][Full Text] [Related]
19. Ligand-Efficient Inhibitors of Trichomonas vaginalis Adenosine/Guanosine Preferring Nucleoside Ribohydrolase.
Muellers SN; Gonzalez JA; Kaur A; Sapojnikov V; Benzie AL; Brown DG; Parkin DW; Stockman BJ
ACS Infect Dis; 2019 Mar; 5(3):345-352. PubMed ID: 30701958
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibition of high and low Mr thioredoxin reductases of parasites by organotelluriums supports the concept that low Mr thioredoxin reductases are good drug targets.
McMillan PJ; Patzewitz EM; Young SE; Westrop GD; Coombs GH; Engman L; Müller S
Parasitology; 2009 Jan; 136(1):27-33. PubMed ID: 18980703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
